Literature DB >> 25785040

Association between CTLA-4 rs231775 polymorphism and risk of colorectal cancer: a meta analysis.

Lijie Wang1, Fangfang Jing1, Dan Su1, Tingting Zhang1, Bo Yang1, Shunchang Jiao1, Yi Hu1, Li Bai1.   

Abstract

OBJECTIVE: Many previous studies that examined the association between CTLA-4 rs231775 polymorphism and CRC risk have produced inconsistent results. In this study, a meta-analysis was performed to systematically summarize the possible association.
METHODS: We identified relevant studies using PubMed, Embase, and China National Knowledge Infrastructure literature databases. Eligible studies were selected using specific criteria. Data were extracted independently by two authors. The pooled OR with 95% CI was estimated by applying the fixed-effects model to examine the association of interest.
RESULTS: Eight studies were identified for the meta-analysis. In overall analysis, we observed an significantly increased CRC risk attributed to the AG genotype as compared to the AA genotype (OR: 1.17, 95% CI: 1.02-1.35 for AG vs AA). Stratified analysis according to ethnicity also showed a significant association in Caucasians under the AG vs AA model (OR: 1.22, 95% CI: 1.03-1.46). No significant heterogeneity or publication bias was tested in our meta-analysis.
CONCLUSION: In conclusion, the meta-analysis suggests that rs231775 in the CTLA-4 gene may be a risk factor for CRC, especially in Caucasians.

Entities:  

Keywords:  CRC; CTLA-4; polymorphism; risk; rs231775

Year:  2015        PMID: 25785040      PMCID: PMC4358495     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  32 in total

1.  Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population.

Authors:  L Bouqbis; H Izaabel; O Akhayat; A Pérez-Lezaun; F Calafell; J Bertranpetit; D Comas
Journal:  Genes Immun       Date:  2003-03       Impact factor: 2.676

2.  Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells.

Authors:  Claire N Manzotti; Helen Tipping; Laura C A Perry; Karen I Mead; Patrick J Blair; Yong Zheng; David M Sansom
Journal:  Eur J Immunol       Date:  2002-10       Impact factor: 5.532

Review 3.  Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer.

Authors:  Laura Baglietto; Mark A Jenkins; Gianluca Severi; Graham G Giles; D Timothy Bishop; Peter Boyle; John L Hopper
Journal:  J Clin Epidemiol       Date:  2006-02       Impact factor: 6.437

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

Authors:  P Lichtenstein; N V Holm; P K Verkasalo; A Iliadou; J Kaprio; M Koskenvuo; E Pukkala; A Skytthe; K Hemminki
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

6.  CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms.

Authors:  A Ligers; N Teleshova; T Masterman; W X Huang; J Hillert
Journal:  Genes Immun       Date:  2001-05       Impact factor: 2.676

Review 7.  Costimulation and autoimmunity.

Authors:  E A Tivol; A N Schweitzer; A H Sharpe
Journal:  Curr Opin Immunol       Date:  1996-12       Impact factor: 7.486

8.  CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction.

Authors:  Elisabetta Contardi; Giulio L Palmisano; Pier Luigi Tazzari; Alberto M Martelli; Federica Falà; Marina Fabbi; Tomohiro Kato; Enrico Lucarelli; Davide Donati; Letizia Polito; Andrea Bolognesi; Francesca Ricci; Sandra Salvi; Vittoria Gargaglione; Stefano Mantero; Marco Alberghini; Giovanni Battista Ferrara; Maria Pia Pistillo
Journal:  Int J Cancer       Date:  2005-11-20       Impact factor: 7.396

9.  CTLA-4 +49A>G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese.

Authors:  Peng Qi; Can-ping Ruan; Hao Wang; Fei-guo Zhou; Xin-yun Xu; Xing Gu; Yun-peng Zhao; Tong-hai Dou; Chun-fang Gao
Journal:  Int J Colorectal Dis       Date:  2009-09-29       Impact factor: 2.571

Review 10.  Cancer disparities by race/ethnicity and socioeconomic status.

Authors:  Elizabeth Ward; Ahmedin Jemal; Vilma Cokkinides; Gopal K Singh; Cheryll Cardinez; Asma Ghafoor; Michael Thun
Journal:  CA Cancer J Clin       Date:  2004 Mar-Apr       Impact factor: 508.702

View more
  4 in total

1.  Comprehensive Analysis of 29,464 Cancer Cases and 35,858 Controls to Investigate the Effect of the Cytotoxic T-Lymphocyte Antigen 4 Gene rs231775 A/G Polymorphism on Cancer Risk.

Authors:  Hongyuan Wan; Hangsheng Zhou; Yanyan Feng; Yongquan Chen; Lijie Zhu; Yuanyuan Mi
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

2.  Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.

Authors:  Shabnam Abtahi; Fatemeh Izadi Jahromi; Mohammad Hossein Dabbaghmanesh; Mahyar Malekzadeh; Abbas Ghaderi
Journal:  Endocrine       Date:  2018-08-04       Impact factor: 3.633

3.  CTLA4 tagging polymorphisms and risk of colorectal cancer: a case-control study involving 2,306 subjects.

Authors:  Chen Zou; Hao Qiu; Weifeng Tang; Yafeng Wang; Bin Lan; Yu Chen
Journal:  Onco Targets Ther       Date:  2018-08-07       Impact factor: 4.147

Review 4.  Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect.

Authors:  Julie Jacobs; Evelien Smits; Filip Lardon; Patrick Pauwels; Vanessa Deschoolmeester
Journal:  J Immunol Res       Date:  2015-10-29       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.